Back

DIGIT­HF: Baseline characteristics compared to recent trials in heart failure with reduced ejection fraction

18 May 2025 (10:45 - 10:53)
Organised by: Logo
Congress Presentation Part of: Hottest trials and trial updates (2) Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Udo Bavendiek

Hannover Medical School, Hannover (Germany)

20 More presentations in this session

Presentation thumbnail
Discussant review - DIGIT­HF
Professor D. van Veldhuisen (Groningen, NL)
Slides Video
Presentation thumbnail
Panel discussion - DIGIT­HF
Video
Presentation thumbnail
CIRRUS­HCM: A multiple-dose phase 2 study of safety, tolerability, and effects on hemodynamics and functional capacity of the novel cardiac sarcomere modulator EDG-7500 in hypertrophic cardiomyopathy
Doctor A. Owens (Philadelphia, US)
Slides Video
Presentation thumbnail
Discussant review - CIRRUS­HCM
Professor I. Olivotto (Florence, IT)
Slides Video
Presentation thumbnail
Panel discussion - CIRRUS­HCM
Video

Access the full session

Session thumbnail
Hottest trials and trial updates (2)
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 10:45 CET
You may be interested in
thumbnail
Congress Presentation
DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
29 August 2025
thumbnail
Congress Presentation
Panel discussion - DIGIT-HF
29 August 2025
thumbnail
Congress Presentation
Chronic heart failure
20 May 2025
thumbnail
Congress Presentation
DECISION/DIGIT-HF/DIG study level meta analysis
10 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources